Dana-Farber Clinical Research Stays on Track During COVID-19
The resilience shown by cancer care providers during the coronavirus crisis is in equal supply among those involved in clinical research. The strict protocols associated with these studies — rules on eligibility, consent, criteria for tracking response, data collection and analysis — might seem to allow little of the flexibility needed in the COVID-19 era. … Read more